Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).

Huber AH, Kampf JP, Kwan T, Zhu B, Adams J 3rd, Kleinfeld AM.

Am J Cardiol. 2014 Jan 15;113(2):279-84. doi: 10.1016/j.amjcard.2013.08.057. Epub 2013 Oct 5.

PMID:
24176067
[PubMed - indexed for MEDLINE]
2.

Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.

Truong QA, Cannon CP, Zakai NA, Rogers IS, Giugliano RP, Wiviott SD, McCabe CH, Morrow DA, Braunwald E.

Am Heart J. 2009 Apr;157(4):673-9.e1. doi: 10.1016/j.ahj.2008.12.010. Epub 2009 Feb 23.

PMID:
19332194
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.

Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E.

J Am Coll Cardiol. 2004 Jul 21;44(2):335-9.

PMID:
15261928
[PubMed - indexed for MEDLINE]
Free Article
4.

Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.

Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, Gibler WB, Stebbins AL, Cianciolo C, Califf RM, Topol EJ.

Am J Cardiol. 1999 Dec 1;84(11):1281-6.

PMID:
10614791
[PubMed - indexed for MEDLINE]
5.

Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.

Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM.

JAMA. 1996 Mar 13;275(10):777-82.

PMID:
8598594
[PubMed - indexed for MEDLINE]
6.

Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.

Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo MJ, Antman EM.

J Am Coll Cardiol. 1999 Feb;33(2):479-87.

PMID:
9973029
[PubMed - indexed for MEDLINE]
Free Article
7.

Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.

Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW.

Circulation. 2007 Dec 4;116(23):2669-77. Epub 2007 Nov 19.

PMID:
18025532
[PubMed - indexed for MEDLINE]
Free Article
8.

Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.

Gibson CM, Pride YB, Aylward PE, Col JJ, Goodman SG, Gulba D, Bergovec M, Kunadian V, Zorkun C, Buros JL, Murphy SA, Antman EM.

J Thromb Thrombolysis. 2009 Jan;27(1):11-7. doi: 10.1007/s11239-008-0264-4. Epub 2008 Aug 10.

PMID:
18695943
[PubMed - indexed for MEDLINE]
9.

Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).

Nikolsky E, Mehran R, Yu J, Witzenbichler B, Brodie BR, Kornowski R, Brener S, Xu K, Dangas GD, Stone GW.

Am J Cardiol. 2013 May 15;111(10):1377-86. doi: 10.1016/j.amjcard.2013.01.285. Epub 2013 Mar 12.

PMID:
23465098
[PubMed - indexed for MEDLINE]
10.

Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.

Langer A, Krucoff MW, Klootwijk P, Simoons ML, Granger CB, Barr A, Califf RM, Armstrong PW.

J Am Coll Cardiol. 1998 Mar 15;31(4):783-9.

PMID:
9525547
[PubMed - indexed for MEDLINE]
Free Article
11.

Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.

Lyngbæk S, Marott JL, Møller DV, Christiansen M, Iversen KK, Clemmensen PM, Eugen-Olsen J, Jeppesen JL, Hansen PR.

Am J Cardiol. 2012 Dec 15;110(12):1756-63. doi: 10.1016/j.amjcard.2012.08.008. Epub 2012 Sep 13.

PMID:
22981263
[PubMed - indexed for MEDLINE]
12.

Extent of ST-segment deviation in the single ECG lead of maximum deviation present 90 or 180 minutes after start of thrombolytic therapy best predicts outcome in acute myocardial infarction.

Schröder K, Wegscheider K, Zeymer U, Neuhaus KL, Schröder R.

Z Kardiol. 2001 Aug;90(8):557-67.

PMID:
11565211
[PubMed - indexed for MEDLINE]
13.

Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.

Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB.

Circulation. 2004 Sep 28;110(13):1754-60. Epub 2004 Sep 20.

PMID:
15381645
[PubMed - indexed for MEDLINE]
Free Article
14.

Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial).

Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR, Dudek D, Möckel M, Ochala A, Mehran R, Stone GW.

Am J Cardiol. 2010 May 15;105(10):1385-94. doi: 10.1016/j.amjcard.2010.01.001. Epub 2010 Apr 2.

PMID:
20451683
[PubMed - indexed for MEDLINE]
15.

[The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].

Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F.

Ital Heart J Suppl. 2000 Jan;1(1):81-7. Italian.

PMID:
10832123
[PubMed - indexed for MEDLINE]
16.

Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).

O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA.

J Am Coll Cardiol. 2014 Apr 29;63(16):1644-53. doi: 10.1016/j.jacc.2013.12.034. Epub 2014 Feb 13. Erratum in: J Am Coll Cardiol. 2014 Jun 17;63(23):2642.

PMID:
24530676
[PubMed - indexed for MEDLINE]
17.

Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.

Vrachatis AD, Alpert MA, Georgulas VP, Nikas DJ, Petropoulou EN, Lazaros GI, Michelakakis NA, Karavidis AI, Lakoumentas JA, Stergiou L, Zacharoulis AA.

Angiology. 2001 Mar;52(3):161-6.

PMID:
11269778
[PubMed - indexed for MEDLINE]
18.

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.

Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E.

Circulation. 1998 Dec 22-29;98(25):2805-14.

PMID:
9860780
[PubMed - indexed for MEDLINE]
Free Article
19.

Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28.

Sherwood MW, Morrow DA, Scirica BM, Jiang S, Bode C, Rifai N, Gerszten RE, Gibson CM, Cannon CP, Braunwald E, Sabatine MS.

Am Heart J. 2010 Jun;159(6):964-971.e1. doi: 10.1016/j.ahj.2010.03.005.

PMID:
20569707
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.

Srinivas VS, Cannon CP, Gibson CM, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E, Mueller HS.

Am Heart J. 2001 Jul;142(1):29-36.

PMID:
11431653
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk